Istari Oncologyincis A Clinical Stage Biotechnology Company Based In Research Triangle Parknorth Carolinathe Company Focuses On Developing Innovative Immunotherapies For Treating Solid Tumorsincluding Glioblastoma And Other Cancersistari Is Dedicated To Improving Cancer Treatment Outcomes Through Pioneering Approaches In Immunotherapy The Company S Primary Asset Is Lerapolturevan Investigational Immunotherapy Derived From The Sabin Oral Poliovirus Vaccinethis Treatment Is Designed To Activate A Systemic Antitumor Response While Minimizing Neurotoxicitylerapolturev Is Currently Being Studied For Its Effectiveness Against Recurrent Glioblastoma And Refractory Melanomaistari Has Partnered With Fujifilm Diosynth Biotechnologies To Enhance The Development Of This Viral Immunotherapy Istari Oncology Has Received Recognition For Its Innovative Workincluding Thebest Early Stage Product Development Companyaward From The Triangle Business Journalthe Company Has Also Achieved Fast Track And Orphan Drug Designation Status From The Fda For Certain Indicationshighlighting Its Commitment To Addressing Significant Unmet Needs In Cancer Care
No conferences found for this company.
| Company Name | Istari Oncology |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
